RaySearch Laboratories AB has received an order for its RayStation® treatment planning system from Institut Paoli-Calmettes (IPC) in Marseille, France.
IPC is a French regional comprehensive cancer center that serves the Provence-Alpes-Côte d’Azur and Corsica region. The center offers all forms of cancer therapy and is also conducting extensive research programs. The hospital has over 1,300 employees and treats around 7,000 new cancer patients annually. IPC will use RayStation® as its treatment planning system for conventional 3D-CRT treatments, as well as more advanced treatments, such as IMRT and VMAT. The order also includes sophisticated solutions, such as multi-criteria optimization, enabling a more efficient treatment planning process. Multi-criteria optimization is a highly intuitive tool that lets the clinician evaluate the impact of changing different treatment priorities in real-time, which has a large potential to speed up the time-consuming plan optimization process.
In addition, IPC will function as a reference clinic for RayStation® meaning that RaySearch will be able to bring potential customers to the clinic to see the system in clinical practice and undergo training. The institute will also have access to research versions of RayStation® that contain all of the latest advanced RayStation® tools that can be evaluated and used in the institute’s research programs.
“RayStation® is the state-of-the-art in treatment planning today so it stood out as the best solution for us. RaySearch also has a very strong development team and we appreciate that we will be able to work with them to create the best possible radiation treatments together”, says Pierre Fau, PhD, Head of the Medical Physics Department at IPC.
Doctor Michel Resbeut, Head of the Radiotherapy Department of IPC, adds: “This cooperation illustrates a global innovation strategy in which our institute has been actively engaged for the last years”.
“I am pleased to welcome Institut Paoli-Calmettes as a reference customer for RayStation® in France, says Johan Löf, CEO of RaySearch. “This is the beginning of a long-term cooperation and we are looking forward to working closely together to further improve the care for cancer patients.”
RayStation® integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron and proton therapy. The system is built on the latest software architecture and has a graphical user interface offering state-of-the-art usability.
RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch’s products are mainly sold through license agreements with leading partners such as Philips, Nucletron, IBA, Varian, Accuray and Brainlab. To date, 15 products have been launched through partners and RaySearch’s software is used at over 2,000 clinics in more than 30 countries. In addition, RaySearch offers the proprietary treatment planning system RayStation® directly to clinics. RaySearch was founded in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30